Mass cytometry and machine learning delineate tumor-defining cells in Sézary syndrome to allow discrimination from benign erythroderma (European Journal of Cancer)

Sezary syndrome is a cutaneous (skin) lymphoma which can be hard to distinguish from atopic dermatitis, a common skin condition. Our platform was able to identify rare tumor-related cells in blood from patients with early stages of Sezary syndrome enabling the rapid and sensitive diagnosis of this life-threatening condition.

Continue reading